Maya Latimer

949 total citations
18 papers, 512 citations indexed

About

Maya Latimer is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Maya Latimer has authored 18 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Genetics. Recurrent topics in Maya Latimer's work include Lymphoma Diagnosis and Treatment (8 papers), Obsessive-Compulsive Spectrum Disorders (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Maya Latimer is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Obsessive-Compulsive Spectrum Disorders (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Maya Latimer collaborates with scholars based in Australia, United States and New Zealand. Maya Latimer's co-authors include Susan E. Swedo, Jakob Seidlitz, Michael Cooperstock, Mark S. Pasternack, Margo Thienemann, Jolán E. Walter, Jennifer Frankovich, Tanya K. Murphy, Madeleine W. Cunningham and Kiki Chang and has published in prestigious journals such as Blood, British Journal of Haematology and Journal of Neuroimmunology.

In The Last Decade

Maya Latimer

16 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maya Latimer Australia	10	260	172	75	66	64	18	512
Maria Joaquina Marques‐Dias Brazil	15	230 0.9×	176 1.0×	75 1.0×	98 1.5×	58 0.9×	38	1.0k
Claudia Colli Italy	10	130 0.5×	137 0.8×	40 0.5×	20 0.3×	95 1.5×	20	544
Antônio Pedro Vargas Brazil	13	91 0.3×	285 1.7×	57 0.8×	49 0.7×	17 0.3×	35	678
José Albino da Paz Brazil	10	111 0.4×	112 0.7×	36 0.5×	51 0.8×	34 0.5×	31	552
Peter Heydemann United States	18	78 0.3×	93 0.5×	99 1.3×	150 2.3×	74 1.2×	36	1.2k
Rick Dersch Germany	21	137 0.5×	555 3.2×	97 1.3×	38 0.6×	332 5.2×	68	1.4k
Sedat Işıkay Türkiye	11	212 0.8×	46 0.3×	105 1.4×	19 0.3×	88 1.4×	64	689
Jerry M.E. Kovoor India	18	42 0.2×	157 0.9×	37 0.5×	33 0.5×	134 2.1×	46	789
Hooshang Hooshmand United States	15	64 0.2×	97 0.6×	116 1.5×	55 0.8×	34 0.5×	41	732
Vrajesh Udani India	16	56 0.2×	90 0.5×	218 2.9×	133 2.0×	39 0.6×	59	917

Countries citing papers authored by Maya Latimer

Since Specialization

Citations

This map shows the geographic impact of Maya Latimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya Latimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya Latimer more than expected).

Fields of papers citing papers by Maya Latimer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maya Latimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya Latimer. The network helps show where Maya Latimer may publish in the future.

Co-authorship network of co-authors of Maya Latimer

This figure shows the co-authorship network connecting the top 25 collaborators of Maya Latimer. A scholar is included among the top collaborators of Maya Latimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maya Latimer. Maya Latimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Polizzotto, Mark N., Sam Milliken, Tara Cochrane, et al.. (2023). Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance. British Journal of Haematology. 201(5). 865–873. 4 indexed citations

Latimer, Maya, Katharine L. Lewis, Chan Y. Cheah, et al.. (2023). Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study. Clinical Lymphoma Myeloma & Leukemia. 23(5). 370–378. 7 indexed citations

Hapgood, Greg, Maya Latimer, Sze Ting Lee, et al.. (2021). Diagnosis, management and follow up of peripheral T‐cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal. 52(10). 1806–1817.

Wight, Joel, Nada Hamad, Belinda A. Campbell, et al.. (2021). Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal. 52(9). 1609–1623. 3 indexed citations

Ross, David M., Nada Hamad, Steven Lane, et al.. (2021). Myeloid somatic mutation panel testing in myeloproliferative neoplasms. Pathology. 53(3). 339–348. 11 indexed citations

Cochrane, Tara, Belinda A. Campbell, Shane Gangatharan, et al.. (2021). Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal. 51(12). 2119–2128.

Latimer, Maya, et al.. (2020). Drug-induced autoimmune haemolytic anaemia in a patient treated with artesunate for malaria infection. Pathology. 52. S110–S110. 1 indexed citations

Shimasaki, Craig, Richard E. Frye, Rosario Rich Trifiletti, et al.. (2019). Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms. Journal of Neuroimmunology. 339. 577138–577138. 34 indexed citations

Rabbolini, David J., Maya Latimer, Shinji Kunishima, et al.. (2017). Diagnosis and treatment ofMYH9-RD in an Australasian cohort with thrombocytopenia. Platelets. 29(8). 793–800. 14 indexed citations

10.

Swedo, Susan E., Jakob Seidlitz, Maya Latimer, et al.. (2015). Clinical Presentation of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections in Research and Community Settings. Journal of Child and Adolescent Psychopharmacology. 25(1). 26–30. 77 indexed citations

11.

Latimer, Maya, et al.. (2015). Therapeutic Plasma Apheresis as a Treatment for 35 Severely Ill Children and Adolescents with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. Journal of Child and Adolescent Psychopharmacology. 25(1). 70–75. 43 indexed citations

12.

Chang, Kiki, Jennifer Frankovich, Michael Cooperstock, et al.. (2014). Clinical Evaluation of Youth with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Recommendations from the 2013 PANS Consensus Conference. Journal of Child and Adolescent Psychopharmacology. 25(1). 3–13. 221 indexed citations

13.

Mulligan, Stephen P., Devinder Gill, Paul Turner, et al.. (2014). Toxicity Is Not Associated with Age or Comorbidity Score in a Randomised Study of Oral Fludarabine and Cyclophosphamide and IV Rituximab (FCR) As First-Line Therapy of Fit, Elderly Patients with Chronic Lymphocytic Leukemia (CLL). Blood. 124(21). 4695–4695. 4 indexed citations

14.

Mulligan, Stephen P., Devinder Gill, Paul Turner, et al.. (2014). A Randomised Dose De-Escalation Study of Oral Fludarabine, ±Oral Cyclophosphamide and Intravenous Rituximab As First-Line Therapy of Fit Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years: Final Analysis of Response and Toxicity. Blood. 124(21). 3325–3325. 11 indexed citations

15.

Senanayake, Sanjaya, Andrea Paparini, Maya Latimer, et al.. (2012). First report of human babesiosis in Australia. The Medical Journal of Australia. 196(5). 350–352. 53 indexed citations

16.

Mulligan, Stephen P., Devinder Gill, Paul Turner, et al.. (2012). A Randomised Dose De-Escalation Safety Study of Oral Fludarabine, ±Oral Cyclophosphamide and Intravenous Rituximab (OFOCIR) As First-Line Therapy of Fit Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years – End of Recruitment Analysis of Response and Toxicity of the Australasian Leukaemia and Lymphoma Group (ALLG) and CLL Australian Research Consortium (CLLARC) CLL5 Study. Blood. 120(21). 436–436. 11 indexed citations

17.

Mulligan, Stephen P., Devinder Gill, Paul Turner, et al.. (2011). 5.25 Safety and Tolerability of Oral Fludarabine, with or without Oral Cyclophosphamide and Intravenous Rituximab Therapy, in Previously Untreated Patients with Chronic Lymphocytic Leukaemia Aged 65 Years or Older: Second Interim Analysis from the Australasian Leukaemia and Lymphoma Group and CLL Australian Research Consortium CLL5 Study. Clinical Lymphoma Myeloma & Leukemia. 11. S259–S260. 1 indexed citations

18.

Donoghue, Martha, et al.. (1998). Hyponatremic Seizure in a Child Using Desmopressin for Nocturnal Enuresis. Archives of Pediatrics and Adolescent Medicine. 152(3). 290–2. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact